RU96102532A - MEANS FOR THE TREATMENT OF NEUROLOGICAL DISEASES - Google Patents

MEANS FOR THE TREATMENT OF NEUROLOGICAL DISEASES

Info

Publication number
RU96102532A
RU96102532A RU96102532/14A RU96102532A RU96102532A RU 96102532 A RU96102532 A RU 96102532A RU 96102532/14 A RU96102532/14 A RU 96102532/14A RU 96102532 A RU96102532 A RU 96102532A RU 96102532 A RU96102532 A RU 96102532A
Authority
RU
Russia
Prior art keywords
treatment
neurological diseases
neurological
diseases
human placenta
Prior art date
Application number
RU96102532/14A
Other languages
Russian (ru)
Other versions
RU2133615C1 (en
Inventor
С.А. Башкатов
Н.А. Борисова
У.М. Джемилев
В.А. Вахитов
Е.К. Алехин
А.Н. Щеглов
А.В. Браженко
И.Ю. Понеделькина
А.В. Чемерис
Д.В. Пахомов
В.А. Мышкин
С.В. Щекин
Л.Е. Костромина
Original Assignee
Институт нефтехимии и катализа с опытным заводом АН РБ
Башкирский государственный медицинский университет
Отдел биохимии и цитохимии УНЦ РАН
Filing date
Publication date
Application filed by Институт нефтехимии и катализа с опытным заводом АН РБ, Башкирский государственный медицинский университет, Отдел биохимии и цитохимии УНЦ РАН filed Critical Институт нефтехимии и катализа с опытным заводом АН РБ
Priority to RU96102532A priority Critical patent/RU2133615C1/en
Priority claimed from RU96102532A external-priority patent/RU2133615C1/en
Publication of RU96102532A publication Critical patent/RU96102532A/en
Application granted granted Critical
Publication of RU2133615C1 publication Critical patent/RU2133615C1/en

Links

Claims (1)

Применение гликозаминогликанов, полученных из плаценты человека, в качестве средства для лечения неврологических заболеваний.The use of glycosaminoglycans derived from human placenta as a means for the treatment of neurological diseases.
RU96102532A 1996-02-13 1996-02-13 Agent for treatment of patient with neurological diseases RU2133615C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96102532A RU2133615C1 (en) 1996-02-13 1996-02-13 Agent for treatment of patient with neurological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96102532A RU2133615C1 (en) 1996-02-13 1996-02-13 Agent for treatment of patient with neurological diseases

Publications (2)

Publication Number Publication Date
RU96102532A true RU96102532A (en) 1998-05-10
RU2133615C1 RU2133615C1 (en) 1999-07-27

Family

ID=20176753

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96102532A RU2133615C1 (en) 1996-02-13 1996-02-13 Agent for treatment of patient with neurological diseases

Country Status (1)

Country Link
RU (1) RU2133615C1 (en)

Similar Documents

Publication Publication Date Title
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
FR2716363B1 (en) Endoscopic therapy instrument.
ITMI942365A0 (en) RETINA FOR ORTHOPEDIC-TRAUMATOLOGICAL SURGERY
ZA983451B (en) Substituted imidazoles useful in the treatment of inflammatory diseases.
ITTO950104A0 (en) CATHETER, PARTICULARLY FOR THE TREATMENT OF CARDIAC ARHYTHMIAS.
FI914213A0 (en) ANORDING FROM THE PATIENT.
TR199501186A2 (en) The process to remove coke from the catalysts.
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
ITVI970167A0 (en) COVERING STRUCTURE FOR THE DRIVER'S POSITION OF OPERATING MACHINES.
ITTO940748A0 (en) PROSTHETIC CONDUIT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
NO20001869D0 (en) Procedures for the treatment of Alzheimer's disease
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
ITTO950099A0 (en) CATHETER, PARTICULARLY FOR THE TREATMENT OF CARDIAC ARHYTHMIAS.
NO913117L (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
MXPA01003761A (en) Remedies for ocular diseases.
HK1038510A1 (en) Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
EA199900298A1 (en) Means for influencing the body
RU96102532A (en) MEANS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
FR2715945B1 (en) Tissue.
GB2354946B (en) Means for the treatment of prion disease